
News|Articles|September 30, 2009
Survey Reveals Biotech Professionals' Attitude Toward New Business Models
A recent, free report, reveals biotech professionals' evaluations of potential business model alternatives for the future.
Advertisement
The following table shows the results of respondents' answers to the question: Given that some of the more traditional avenues to drug development could be facing problems, from the list below please indicate any change in your company’s stance or relative interest in using each drug development model/partner. As you will see from the following responses, choices varied greatly.
Source: Industry Standard Research, 2009.
You can view the full report
For more information on biotech, please see:
More Data Points:
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
A Shot in the Arm to Traditional Vaccine Trial Strategy
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
SCOPE X: What Real-Time Patient Data Is Doing to ClinOps Efficiency
5




